San Diego-centered Viking Therapeutics marked alone as a significant competitor from the weight loss drug market in February soon after revealing promising info from a mid-stage trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when supplied to be a weekly injection As well as in March the compa